 Ketamine is a sedative or anesthetic, depending on the dose. The drug is approved by the US Food and Drug Administration FDA and is commonly used in children and adults. Animal studies and case reports in humans suggest that ketamine may reduce the symptoms of Rett syndrome. The purpose of this study is to determine the safety and efficacy of ketamine for treating breathing and behavioral symptoms of RTT. 